Brief: Elevation Oncology Reports Fourth Quarter And Full Year 2021 Financial Results
03/03/2022 12:51
March 3 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS
* ELEVATION ONCOLOGY - AS OF DEC 31, 2021, HAD CASH,
EQUIVALENTS
$146.3 MILLION, WHICH IS EXPECTED TO FUND CURRENT OPERATIONS
INTO Q2 2023
Source text for Eikon: ID:nPn81GjB2a
Further company coverage: ELEV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing